StockNews.com started coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “buy” rating on the medical instruments supplier’s stock.
Pro-Dex Stock Performance
NASDAQ PDEX opened at $16.11 on Monday. The company has a fifty day simple moving average of $17.96 and a 200 day simple moving average of $17.23. Pro-Dex has a 12-month low of $14.47 and a 12-month high of $21.43. The company has a current ratio of 3.07, a quick ratio of 1.58 and a debt-to-equity ratio of 0.36. The company has a market cap of $57.11 million, a P/E ratio of 12.69 and a beta of 0.97.
Institutional Trading of Pro-Dex
Several hedge funds have recently bought and sold shares of PDEX. Tower Research Capital LLC TRC grew its position in Pro-Dex by 345.6% in the 3rd quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 2,084 shares during the period. UBS Group AG grew its position in Pro-Dex by 421.5% in the 1st quarter. UBS Group AG now owns 5,867 shares of the medical instruments supplier’s stock valued at $96,000 after purchasing an additional 4,742 shares during the period. Renaissance Technologies LLC purchased a new position in Pro-Dex during the 2nd quarter worth $168,000. State Street Corp boosted its holdings in Pro-Dex by 5.8% during the 1st quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier’s stock worth $197,000 after acquiring an additional 650 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Pro-Dex by 59.2% during the 1st quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier’s stock worth $345,000 after acquiring an additional 7,762 shares during the last quarter. Institutional investors and hedge funds own 14.61% of the company’s stock.
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
- Five stocks we like better than Pro-Dex
- 3 Best Fintech Stocks for a Portfolio Boost
- 2 Stocks to Get You Ready for the Holiday Season
- Short Selling: How to Short a Stock
- Profit Potential: 5 Undervalued Stocks With High Dividend Yields
- How to Invest in Grocery Stores
- MarketBeat Week in Review – 8/21 – 8/25
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.